Refining genetic associations in multiple scle... [Lancet Neurol. 2008] - PubMed

loading

Review Inheritance of susceptibility to multiple sclerosis. [Curr Opin Immunol. 1998]
Review Inheritance of susceptibility to multiple sclerosis.
Sawcer S, Goodfellow PN. Curr Opin Immunol. 1998 Dec; 10(6):697-703.
Mapping genetic susceptibility to multiple sclerosis. [Lancet. 1996]
Mapping genetic susceptibility to multiple sclerosis.
Farrall M. Lancet. 1996 Dec 21-28; 348(9043):1674-5.
Microsatellites and genome scans-- a GAMES postscript. [J Neuroimmunol. 2007]
Microsatellites and genome scans-- a GAMES postscript.
Dyment DA, Ebers GC. J Neuroimmunol. 2007 Oct; 190(1-2):5-7. Epub 2007 Aug 31.
Review Genetics of multiple sclerosis. [Neurol Clin. 2005]
Review Genetics of multiple sclerosis.
Oksenberg JR, Hauser SL. Neurol Clin. 2005 Feb; 23(1):61-75, vi.
A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility. [J Neuroimmunol. 2009]
A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility.
Bonetti A, Koivisto K, Pirttilä T, Elovaara I, Reunanen M, Laaksonen M, Ruutiainen J, Peltonen L, Rantamäki T, Tienari PJ. J Neuroimmunol. 2009 Mar 31; 208(1-2):119-24. Epub 2009 Feb 4.

Systematic review of genome-wide expression studies in multiple sclerosis. [BMJ Open. 2011]
Systematic review of genome-wide expression studies in multiple sclerosis.
Kemppinen AK, Kaprio J, Palotie A, Saarela J. BMJ Open. 2011 Jan 1; 1(1):e000053. Epub 2011 Jul 18.
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. [Genome Med. 2011]
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
Wang JH, Pappas D, De Jager PL, Pelletier D, de Bakker PI, Kappos L, Polman CH, Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Chibnik LB, Hafler DA, et al. Genome Med. 2011 Jan 18; 3(1):3. Epub 2011 Jan 18.
Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future. [Ther Adv Neurol Disord. 2009]
Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future.
De Jager PL. Ther Adv Neurol Disord. 2009 Nov; 2(6):8-19.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
SNP (Cited)
Nucleotide polymorphism records from dbSNP that have NCBI dbSNP identifiers reported in the PubMed abstract of the current articles.
Taxonomy via GenBank
Taxonomy records associated with the current articles through taxonomic information on related molecular database records (Nucleotide, Protein, Gene, SNP, Structure).
SNP
Nucleotide polymorphism records from dbSNP that have current articles as submitter-provided references.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Refining genetic associations in multiple sclerosis.
Refining genetic associations in multiple sclerosis.
Lancet Neurol. 2008 Jul ;7(7):567-9.

PubMed
Iodine requirements and the risks and benefits of correcting iodine deficiency i...
Iodine requirements and the risks and benefits of correcting iodine deficiency in populations.
J Trace Elem Med Biol. 2008 ;22(2):81-92. Epub 2008 May 7 .

PubMed
Clinical controversies: etomidate as an induction agent for endotracheal intubat...
Clinical controversies: etomidate as an induction agent for endotracheal intubation in patients with sepsis: continue to use etomidate for intubation of patients with septic shock.
Ann Emerg Med. 2008 Jul ;52(1):13-4.

PubMed
Modeling, analysis, and validation of a novel HIV integrase structure provide in...
Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
J Mol Biol. 2008 Jul 11 ;380(3):504-19. Epub 2008 May 1 .

PubMed
Natural jasmonates of different structures suppress the growth of human neurobla...
Natural jasmonates of different structures suppress the growth of human neuroblastoma cell line SH-SY5Y and its mechanisms.
Acta Pharmacol Sin. 2008 Jul ;29(7):861-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed